Brainstorm to announce third quarter 2023 financial results and provide a corporate update

New york , nov. 7, 2023 /prnewswire/ -- brainstorm cell therapeutics inc. (nasdaq: bcli), a leading developer of cellular therapies for neurodegenerative diseases, announced today that it will hold a conference call on tuesday, november 14 th at 8:30 a.m. eastern time to discuss its financial results for the third quarter ended september 30, 2023 and provide a corporate update.
BCLI Ratings Summary
BCLI Quant Ranking